CRIS Current Research Information System

TAGLIERI, NEVIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.207
EU - Europa 4.379
AS - Asia 1.963
AF - Africa 409
SA - Sud America 10
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 12.978
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.197
GB - Regno Unito 1.248
SE - Svezia 708
DE - Germania 641
IT - Italia 628
CN - Cina 552
VN - Vietnam 489
SG - Singapore 456
IN - India 287
IE - Irlanda 244
UA - Ucraina 222
RU - Federazione Russa 164
FR - Francia 152
TG - Togo 129
BG - Bulgaria 99
CI - Costa d'Avorio 95
EE - Estonia 93
ZA - Sudafrica 91
JO - Giordania 86
NG - Nigeria 77
CH - Svizzera 61
IR - Iran 36
BE - Belgio 34
FI - Finlandia 24
JP - Giappone 17
SC - Seychelles 16
NL - Olanda 14
CA - Canada 9
AT - Austria 8
KR - Corea 8
RO - Romania 7
BR - Brasile 6
HR - Croazia 6
AU - Australia 5
GR - Grecia 5
LB - Libano 5
TR - Turchia 5
UZ - Uzbekistan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
MK - Macedonia 3
PK - Pakistan 3
PT - Portogallo 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
CL - Cile 2
LA - Repubblica Popolare Democratica del Laos 2
MN - Mongolia 2
PL - Polonia 2
TH - Thailandia 2
AL - Albania 1
AM - Armenia 1
AR - Argentina 1
EC - Ecuador 1
EG - Egitto 1
ES - Italia 1
EU - Europa 1
IL - Israele 1
IS - Islanda 1
KG - Kirghizistan 1
LT - Lituania 1
LU - Lussemburgo 1
MX - Messico 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
SI - Slovenia 1
TW - Taiwan 1
Totale 12.978
Salva come PNG Salva come JPEG
Città #
Southend 1.113
Fairfield 748
Chandler 706
Ashburn 500
Singapore 392
Woodbridge 362
Houston 349
Wilmington 346
Seattle 319
Ann Arbor 299
Princeton 285
Cambridge 258
Dublin 242
Dong Ket 203
Jacksonville 131
Lomé 129
Westminster 116
Bremen 108
Nanjing 108
Padova 107
New York 102
Turin 102
Berlin 98
Sofia 98
Abidjan 95
Bologna 93
Amman 86
Abeokuta 77
Santa Clara 72
Boardman 57
Saint Petersburg 56
Beijing 53
San Diego 53
Bern 52
Milan 44
Changsha 42
Shenyang 41
Medford 40
Nanchang 39
Dearborn 38
Hebei 35
Jinan 35
Brussels 33
Jiaxing 27
Mülheim 27
Pune 26
Los Angeles 25
Norwalk 22
Helsinki 21
Olalla 21
Mountain View 20
Redmond 19
Falls Church 18
Tianjin 18
Des Moines 17
Lanzhou 17
Florence 16
Guangzhou 16
Kuban 15
Mahé 15
Verona 15
Washington 15
Zhengzhou 15
Haikou 13
Tokyo 13
Ardabil 12
Bühl 12
Leawood 12
Rome 12
Taiyuan 12
London 11
Paris 11
Frankfurt am Main 10
Redwood City 10
Taizhou 10
Zanjan 10
Hangzhou 9
Kunming 9
Hefei 7
Andover 6
Buffalo 6
Monmouth Junction 6
Ningbo 6
San Venanzo 6
Toronto 6
Forlì 5
Genoa 5
Groningen 5
Orange 5
Cernusco sul Naviglio 4
Costa Mesa 4
Guri-si 4
Hyderabad 4
Kilburn 4
Reggio Emilia 4
Rostock 4
Amsterdam 3
Augusta 3
Bad Lippspringe 3
Buccinasco 3
Totale 8.916
Salva come PNG Salva come JPEG
Nome #
Detection of Tissue Factor Antigen and Coagulation Activity in Coronary Artery Thrombi Isolated from Patients with ST-Segment Elevation Acute Myocardial Infarction 175
Acute kidney injury following transcatheter aortic valve implantation: incidence, predictors and clinical outcome. 171
Clinical comparison of "normal-hours" vs "off-hours" percutaneous coronary interventions for ST-elevation myocardial infarction. 159
L’angioplastica delle arterie polmonari nel cuore polmonare cronico tromboembolico: 5 anni di esperienza in Italia 156
Cognitive functions: Evaluation and changes after transcatheter aortic valve implantation in elderly patients 155
Acute kidney injury following transcatheter aortic valve implantation: incidence, predictors and 1-year clinical outcome 155
Incidence and Outcome of High On-Treatment Platelet Reactivity in Patients With Non-ST Elevation Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention (from the VIP [VerifyNow and Inhibition of Platelet Reactivity] Study) 154
Baseline white blood cell count is an independent predictor of long-term cardiovascular mortality in patients with non-ST-segment elevation acute coronary syndrome, but it does not improve the risk classification of the GRACE score. 150
32P brachytherapy in the treatment of complex Cypher in-stent restenosis. 149
Carbon dioxide coronary angiography: A mechanical feasibility study with a cardiovascular simulator 149
Vascular complications after balloon aortic valvuloplasty in recent years: Incidence and comparison of two hemostatic devices 142
Balloon aortic valvuloplasty as a bridge-to-decision in high risk patients with aortic stenosis: A new paradigm for the heart team decision making 139
[Cystatin C and cardiovascular risk. 137
Cystatin C and Cardiovascular Risk 135
Angioplastica delle arterie polmonari nel cuore polmonare cronico tromboembolico: un caso clinico paradigmatico 135
Optimisation of therapeutic strategies for ST-segment elevation acute myocardial infarction: the impact of a territorial network on reperfusion therapy and mortality 132
Clinical relevance of homocysteine levels in patients receiving coronary stenting for unstable angina. 131
Troponin T elevation in acute aortic syndromes: Frequency and impact on diagnostic delay and misdiagnosis 130
Incidence, treatment, and outcome of acute aortic valve regurgitation complicating percutaneous balloon aortic valvuloplasty 129
Emerging indications, in-hospital and long-term outcome of balloon aortic valvuloplasty in the transcatheter aortic valve implantation era. 127
Long-term effectiveness of early administration of glycoprotein IIb/IIIa agents to real-world patients undergoing primary percutaneous interventions: results of a registry study in an ST-elevation myocardial infarction network. 127
How many patients with severe symptomatic aortic stenosis excluded for cardiac surgery are eligible for transcatheter heart valve implantation? 126
Diagnostic performance of standard electrocardiogram for prediction of infarct related artery and site of coronary occlusion in unselected STEMI patients undergoing primary percutaneous coronary intervention 125
Cardiac FDG PET/CT is useful to assess the culprit lesion in nonST-segment elevation myocardial infarction (NSTEMI). 124
Is balloon aortic valvuloplasty safe in patients with significant aortic valve regurgitation? 123
Incidence, treatment and outcome of acute coronary syndromes: A community-based study in the era of myocardial infarction networks. 122
Biolimus-A9 eluting stent implantion for unprotected left main coronary artery stenosis: 9-month strut coverage as assessed by optical coherence tomography 121
Prodromal angina and risk of 2-year cardiac mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous intervention 121
Randomized comparative trial of a thin-strut bare metal cobalt-chromium stent versus a sirolimus-eluting stent for coronary revascularization 119
Long-term clinical and angiographic outcome of patients with occlusive in-stent restenosis treated with (32P) beta-brachytherapy. 118
La brachiterapia endocoronarica nei pazienti diabetici con ristenosi intrastent. 118
The role of percutaneous balloon aortic valvuloplasty as a bridge for transcatheter aortic valve implantation. 117
Prognostic significance of shockable and non-shockable cardiac arrest in ST-segment elevation myocardial infarction patients undergoing primary angioplasty 117
Clinical impact of direct referral to primary percutaneous coronary intervention following pre-hospital diagnosis of ST-elevation myocardial infarction. 117
Impact of a territorial ST-segment elevation myocardial infarction network on prognosis of patients with out-of-hospital cardiac arrest. 117
Coronary artery disease and reasonably incomplete coronary revascularization in high-risk patients undergoing transcatheter aortic valve implantation 117
Cardiac FDG PET/CT to Assess the Culprit Lesion during Acute Infarction 116
Cistatina C and rischio cardiovascolare 115
Differential effect of everolimus on progression of early and late cardiac allograft vasculopathy in current clinical practice. 115
Predictors of complicated athero-thrombotic lesions in non-ST segment acute coronary syndrome. 114
Inferior Q waves in apparently healthy subjects: Should we take a deep breath? An electrocardiographic, echocardiographic and cardiac magnetic resonance study 112
Efficacy and safety of thrombus aspiration in ST-segment elevation myocardial infarction: an updated systematic review and meta-analysis of randomised clinical trials 112
TCT-670 Incidence, Treatment And Outcome Of Acute Aortic Valve Regurgitation Complicating Percutaneous Balloon Aortic Valvuloplasty 111
Short- and long-term prognostic significance of ST-segment elevation in lead aVR in patients with non-ST-segment elevation acute coronary syndrome. 111
What is the acceptable rate of false positives for STEMI within a primary PCI network? Insights from a metropolitan system with direct ambulance-based access. 111
Detection of tissue factor antigen and coagulation activity in coronary artery thrombi isolated from patients with ST-segment elevation acute myocardial infarction 110
Differential Effect of Everolimus and Metabolic Risk Factors on Early vs. Late Progression of Allograft Vasculopathy: Dissecting Two Faces of the Same Disease 109
Long-term prognostic role of cerebrovascular disease and peripheral arterial disease across the spectrum of acute coronary syndromes 108
Relation between thoracic aortic inflammation and features of plaque vulnerability in the coronary tree in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention. An FDG-positron emission tomography and optical coherence tomography study 107
Transcatheter aortic valve implantation with a self-expanding nitinol bioprosthesis: prediction of the need for permanent pacemaker using simple baseline and procedural characteristics. 106
Pre-hospital ECG in patients undergoing primary percutaneous interventions within an integrated system of care: reperfusion times and long-term survival benefits. 106
Usefulness of prehospital triage in patients with cardiogenic shock complicating ST-elevation myocardial infarction treated with primary percutaneous coronary intervention 105
Cystatin C and cardiovascular risk. 104
Interplay of coronary angiography and intravascular ultrasound in predicting long-term outcomes after heart transplantation 104
Risk of stroke in patients with stable coronary artery disease undergoing percutaneous coronary intervention versus optimal medical therapy: Systematic review and meta-analysis of randomized controlled trials 104
Lower long-term mortality within a regional system of care for ST-elevation myocardial infarction. 102
Mid-term and long-term mortality associated with heart failure in patients hospitalized for acute coronary syndromes 102
Left Main Coronary Artery Compression in Patients With Pulmonary Arterial Hypertension and Angina 102
Prognostic significance of mean platelet volume on admission in an unselected cohort of patients with non ST-segment elevation acute coronary syndrome. 102
Secondary prevention medical therapy and outcomes in patients with myocardial infarction with non-obstructive coronary artery disease 100
Left ventricular function after ST-elevation myocardial infarction in patients treated with primary percutaneous coronary intervention and abciximab or tirofiban (from the Facilitated Angioplasty with tirofiban or Abciximab [FATA] trial) 99
Randomized comparison between tirofiban and abcximab to promote complete ST-resolution in primary angioplasty: results of the facilitated angioplasty with tirofiban or abcximab (FATA) in ST-elevation myocardial infarction trial 98
Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated by percutaneous coronary intervention 98
Acute hand ischemia after radial intervention in patient with CREST-associated pulmonary hypertension: successful treatment with manual thromboaspiration. 98
EVEROLIMUS REDUCES CAV PROGRESSION AS COMPARED WITH AZATHIOPRINE AND MYCOPHENOLATE: A LONGITUDINAL IVUS- BASED STUDY 98
Movement compensation during carbon dioxide coronary angiography: In-vitro validation 98
Early vs. late IIb/IIIa agents administration in primary percutaneous interventions for ST-elevation myocardial infarction: results of a single centre registry 97
Impact of gene polymorphisms, platelet reactivity, and the SYNTAX score on 1-year clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: The GEPRESS study 97
Risk of stroke in patients with high on-clopidogrel platelet reactivity to adenosine diphosphate after percutaneous coronary intervention 97
Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated with percutaneos coronary intervention 96
Differential Effects of Everolimus on Early vs. Late Allograft Vasculopathy Progression in Heart Transplant Recipients: a Longitudinal IVUS-Based Study 95
Peripheral arterial disease and long-term mortality following acute coronary syndromes: insights from a large registry of unselected patients 95
How should i treat an unexpected deadlock at the time of transcatheter aortic valve prosthesis implantation? 95
The role of percutaneous aortic bloon valvuloplasty for severe degenerative aortic valve stenosis in the modern era of interventional cardiology 93
Risk of stroke with percutaneous coronary intervention compared with on-pump and off-pump coronary artery bypass graft surgery: Evidence from a comprehensive network meta-analysis. 93
Long-term effectiveness of early administration of IIb/IIIa agents to high-risk patients undergoing primary percutaneous interventions 92
PREDICTING CARDIOVASCULAR OUTCOMES LONG-TERM AFTER HEART TRANSPLANT BY LATE CHANGES IN MAXIMAL INTIMAL THICKNESS: BEYOND THE HYSTORICAL 1-YEAR LIMIT 92
Late Changes in Maximal Intimal Thickness after Heart Transplant: Prognostic Implications and Risk Factors 91
Repeated Aortic Balloon Valvuloplasty in Elderly Patients With Aortic Stenosis Who Are Not Candidates for Definitive Treatment 91
Standard ECG to predict culprit left main disease in unselected patients with non ST-segment elevation acute coronary syndrome 89
Biolimus-a9 eluting stent implantion for unprotected left main coronary artery stenosis: 9-month strut coverage as assessed by optical coherence tomography 89
Relation between angiographic lesion severity, vulnerable plaque morphology and future adverse cardiac events (from the Providing Regional Observations to Study Predictors of Events in the Coronary Tree study). 88
Effect of cerebrovascular disease on long-term outcome of patients with acute coronary syndromes: findings from a large cohort of unselected patients 88
Residual aortic regurgitation is a major determinant of late mortality after transcatheter aortic valve implantation 88
Role of residual acute stent malapposition in percutaneous coronary interventions 88
Riduzione del tempo di ritardo terapeutico e della mortalità ospedaliera nei pz con STEMI grazie ad un programma di accesso rapido alla PTCA primaria 87
SHORT AND LONG-TERM PROGNOSTIC SIGNIFICANCE OF ST-SEGMENT ELEVATION IN LEAD AVR IN PATIENTS WITH NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME 87
Plasma cystatin C for prediction of 1-year cardiac events in Mediterranean patients with non-ST elevation acute coronary syndrome. 86
Reply: Left Main Extrinsic Compression in Pulmonary Arterial Hypertension: From Identification to Percutaneous Coronary Intervention Optimization 86
One-year outcome of patients eligible to transcatheter aortic valve implantation according to actual treatment 86
Circulating miR-184 is a potential predictive biomarker of cardiac damage in Anderson–Fabry disease 86
Prognostic significance of mean platelet volume on admission in unselected cohort of patients with non ST-segment elevation acute coronary syndrome 85
Left ventricular recovery after ST-elevation myocardial infarction in patients treated with primary coronary angioplasty and abciximab or tirofiban 84
Female gender and mortality in ST-segment-elevation myocardial infarction treated with primary PCI 84
Predictors of 32P h brachytherapy failure in patients with high-risk in-stent restenosis 83
Occurrence of major bleeding during long-term follow up of unselected patients with STE vs NSTE Acute Coronary Syndromes 82
Percutaneous coronary intervention following thrombolysis: for whom and when? 82
Imaging Myocardium at Risk and Coronary Inflammation in Non-ST-Segment Elevation Myocardial Infarction: Combined Use of FDG PET and Optical Coherence Tomography. 81
Diagnostic performance of standard electrocardiogramfor prediction of site of coronary occlusion in unselected anterior STEMI patients 81
Risk of stroke in patients with high on clopidrogel platelet reactivity to ADP after percutaneous coronary intervention: systematic review and meta-analysis 80
Totale 11.030
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.494
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.494
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.524 0 0 35 180 303 318 371 384 404 220 139 170
2020/20211.632 368 103 55 67 13 59 25 77 179 77 63 546
2021/20222.491 200 120 145 222 204 120 49 193 85 188 518 447
2022/20233.267 268 458 176 450 268 267 77 179 593 83 281 167
2023/2024985 70 125 49 117 86 309 35 54 21 60 30 29
2024/2025763 196 484 83 0 0 0 0 0 0 0 0 0
Totale 13.406